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Blood gas analysis (BGA) is exposed to risks of errors caused by improper sampling, transport and storage conditions. The Clinical and Laboratory 
Standards Institute (CLSI) generated documents with recommendations for avoidance of potential errors caused by sample mishandling. Two main 
documents related to BGA issued by the CLSI are GP43-A4 (former H11-A4) Procedures for the collection of arterial blood specimens; approved stan-
dard – fourth edition, and C46-A2 Blood gas and pH analysis and related measurements; approved guideline – second edition. 
Practices related to processing of blood gas samples are not standardized in the Republic of Croatia. Each institution has its own protocol for orde-
ring, collection and analysis of blood gases. Although many laboratories use state of the art analyzers, still many preanalytical procedures remain 
unchanged.
The objective of the Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM) is to standardize the procedures for BGA based 
on CLSI recommendations. The Working Group for Blood Gas Testing as part of the Committee for the Scientific Professional Development of the 
CSMBLM prepared a set of recommended protocols for sampling, transport, storage and processing of blood gas samples based on relevant CLSI 
documents, relevant literature search and on the results of Croatian survey study on practices and policies in acid-base testing.
Recommendations are intended for laboratory professionals and all healthcare workers involved in blood gas processing.
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Introduction 
The term “blood gas analysis” (BGA) is used for lab-
oratory testing that relates to acid-base balance 
and oxygenation status of a patient. Oxygenation 
status is assessed using partial pressure of O2 (pO2) 
and haemoglobin oxygen saturation (sO2). Partial 
pressure of O2 (pO2) is measured by amperometry, 
while sO2 is measured by co-oximetry. Blood gas 
analysers that do not have integrated co-oximeter, 
report sO2 estimated from pO2 and other parame-
ters. Potentiometry is used for pH and partial pres-
sure of CO2 (pCO2) measurement. Other reported 
parameters like total CO2 (tCO2), bicarbonate con-
centration (cHCO3-) and base excess (BE) are calcu-
lated from the measured values. Current analyzers 
measure not just blood gas parameters but elec-
trolytes (sodium, potassium, chloride, ionized cal-
cium, ionized magnesium) and metabolites (glu-
cose, lactate, bilirubin, creatinine). These addition-
al analytes are usually named as “related measure-
ments” (1). According to the document issued by 
the Croatian Chamber of Medical Biochemists 
(CCMB), BGA is categorized as first priority analysis 
which should be reported within 30 minutes (2).
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Emergency and intensive care departments use 
BGA as indispensable part of assessment of pa-
tient’s clinical status (3). Stressful and hectic envi-
ronment often multiplies probability of errors 
which could result in the adverse patient out-
comes (4). Incentive for preparation of recommen-
dations in this field of laboratory diagnostics was 
created by the Working Group for Blood Gas Test-
ing (WG BGT) of the Croatian Society of Medical 
Biochemistry and Laboratory Medicine (CSMBLM). 
The survey on policies and practices of BGA in Cro-
atia facilitated the identification of crucial issues 
(5). Survey results showed great heterogeneity in 
procedures related to BGA in Croatian laborato-
ries. Standardization of ordering, collection and 
analysis are needed to achieve higher level of lab-
oratory diagnostics of blood gases and related 
measurements. Based on these crucial points and 
current global guidelines, members of the WG BGT 
made joint effort in establishment of recommen-
dations for blood gas testing, covering the preana-
lytical phase of blood gas testing, sampling proce-
dure, BGA and quality control. Due to the wide use 
of Point of Care Testing (POCT) instruments for 
blood gas testing, special attention is required to 
protocols related to their use by non-laboratory 
personnel. The POCT Working Group of CSMBLM 
will prepare the national recommendations for 
that part of laboratory diagnostics.
The national recommendations for BGT on behalf of 
the CSMBLM are intended for laboratory profession-
als and non-laboratory personnel involved in BGT.
This document is divided in the following sections:
1. Sample types used for blood gas analysis,
2. Responsibilities in blood gas testing,
3. Procedure for blood gas sampling, and
4. Blood gas sample analysis.
Specific recommendations of the Working Group 
are labelled by the boxes. Each recommendation 
is followed by relevant data from literature. 
1 . Sample types used for BGA
Different sample types can be used for blood gas 
measurement – arterial blood, “arterialized” capil-
lary, “mixed” venous blood and venous blood (1). 
Clinician should consider the patient’s condition, 
advantages and limitations of various sample 
types when deciding on the most suitable sample 
type and collection site (6).
1.1 Arterial blood 
Figure 1. Main arteries. 
(a) arm – radial and brachial arteries are puncture sites whereas 
collateral circulation to the hand is provided by the ulnar artery. 
(b) groin – femoral artery is the puncture site (figure shows an-
atomically sub-divided parts of the femoral artery – common 









Arterial blood is the sample type required for 
correct assessment of gas exchange, function of 
the lungs (pO2 and pCO2), specifically oxygena-
tion status. Composition of the arterial blood is 
uniform and it is not dependent on changes in 
systemic or local circulation. Arterial blood is the 
preferred sample type for evaluation of respira-
tory status, as well as being suitable for meta-
bolic acid-base disorders.
Sample collection can be performed by using spe-
cifically designed arterial blood sample syringes or 
through arterial line (1). Usual sites of arterial punc-
ture are radial, brachial or femoral artery (Figure 1.) 
(6,7). Puncture site has to be aseptic (7). 
Criteria for the selection of the puncture site are 
following: presence of adequate collateral blood 
flow, size and accessibility of the artery (7).
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1.1.1 Radial artery
The radial artery is the most commonly used site for 
arterial puncture. It is easily accessible at the thumb 
side of the wrist, but because of its small size, use of 
this artery requires an extensive experience in arte-
rial blood sampling (7,8). Collateral circulation to 
the hand is normally provided by the ulnar artery, 
which can be absent in some individuals. 
1.1.2 Brachial artery
The brachial artery may be preferred for larger vol-
umes of arterial blood. It is more difficult to punc-
ture due to the deeper location between muscles 
and connective tissues. It is not easily accessible in 
obese patients, and is not commonly used in chil-
dren and infants (7). 
1.1.3 Femoral artery
The femoral artery is a large vessel which is easily 
palpated and punctured, but it is rarely used in 
clinical practice due to the poor collateral circula-
tion and increased chance of infection and hema-
toma (7). The computed tomography (CT) images 
have revealed a high frequency of small hemato-
ma (47.4%) around the femoral artery after arterial 
blood sampling (9).
Collection of arterial blood has its disadvantages. 
It is more difficult to obtain than venous or capil-
lary blood sample, it is more painful for the patient 
and it can be potentially dangerous, if the correct 
procedure is not followed (1). Risks related to arte-
rial blood collection include pain perceived by pa-
tient and serious infections due to highly invasive 
manoeuvre. Moreover, a haemostasis not perfect-
ly performed could be a source of damage, hema-
tomas and haemorrhagia. Usual complications of 
the procedure are the following: arteriospasm, he-
matoma, nerve damage, fainting and drop in 
blood pressure (10). 
1.2 “Arterialized” capillary sample
when an arterialisation technique is used, al-
though entirely reliable pO2 measurement can 
be achieved only when an arterial blood sample 
is used. Skin puncture is also applicable for adult 
patients with severe burns, tendencies to 
thrombosis, obese and geriatric patients.
A capillary blood sample can be considered as 
an adequate substitute for the arterial blood in 
neonatal and paediatric units. A capillary blood 
sample can replace an arterial sample only 
According to the survey study on practices and 
policies in acid-base testing in Croatian laborato-
ries, a capillary sample is a sample type used in 
most of the institutions in Croatia. Survey results 
showed that 19 out of 41 participants (or 0.46) 
have a capillary sample taken for BGA in an adult 
patient population. The same survey showed that 
only 7 laboratories out of 33 (or 0.21) analyze exclu-
sively arterial samples for BGA. Avoidance of arteri-
al sample collection can be attributed to economic 
factors and difficulty of collection. Many physicians 
are accustomed to order capillary BGA as a part of 
the regular patient follow-up together with bio-
chemistry and haematology testing (5).
Capillary blood collection is a simple, relatively 
painless procedure that can be performed after a 
minimal training of medical personnel, but it has its 
disadvantages. Zavorsky et al. compared laborato-
ry results of BGA conducted in arterial and capillary 
blood samples. Results showed that arterialized 
capillary blood is a suitable alternative for meas-
urement of pH and pCO2 over a wide range of val-
ues, but it is not suitable for pO2 (11). Arterial blood 
pO2 is physiologically higher than the arterialized 
capillary pO2 because of the oxygen consumption 
in skin capillary bed. The possibility of arterialized 
capillary sample accurately predicting arterial pO2 
is improved when the arterial pO2 is low because 
arteriovenous difference is reduced in hypoxia (11). 
There are some circumstances in which arterial 
blood cannot be collected directly and capillary 
blood sample can be considered as an adequate 
substitute for the arterial blood (1,8,12). In neona-
tal and paediatric units capillary blood sample is 
desirable sample type because infants and small 
children have small total volume of blood and fre-
quent blood collection can result in anaemia (8,12-
14). Skin puncture is also applicable for adult pa-
tients with severe burns, tendencies to thrombo-
sis, obese and geriatric patients (8,12).
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A capillary blood sample can replace arterial sam-
ple (but not for pO2) only when an arterialisation 
technique is used (1). A warmed capillary sample 
approximates an arterial specimen (1,7) because 
portion of arterial blood in capillary sample can be 
increased up to seven fold by using an arterialisa-
tion technique (12). This technique consists of use 
of a warm, moist towel at a temperature not high-
er than 42 °C on a puncture site not longer than 
three to five minutes (12) or use of other vasodila-
tor agent (6).
1.2.1 Puncture site
1.2.2 Precaution measures for capillary blood gas 
sampling
There are multiple risks for preanalytical errors 
when collecting capillary blood: gas exchange 
with air (1); strong, repetitive pressure on puncture 
site – “milking” should be avoided, as it can cause 
haemolysis and contamination of the sample with 
tissue fluid, ultimately resulting in elevated potas-
sium levels and dilution of blood, causing lower 
values for other electrolytes (1,17). Finally thor-
ough mixing of the blood is necessary to prevent 
clotting (12). 
It is important to be aware of these limitations of a 
capillary sample when selecting a blood gas col-
lection site. 
1.3 Venous blood sample
Recommended puncture site for capillary sam-
pling is the fingertip or heel, depending on the 
patient age (12). Lateral or medial plantar sur-
face of the heel is the puncture site for neonatal 
population, while the fingertip is recommended 
for paediatric population (1,12).
Recent studies show earlobe sampling has ad-
vantage over fingertip capillary sampling when 
capillary blood gas sampling for an adult pa-
tient is considered.
The CLSI document on a capillary sample GP42-A6 
recommends capillary sampling be performed by 
puncturing the skin on a finger or heel, depending 
on the age of the patient. In neonates, the recom-
mendation is to perform punctures on the lateral 
or medial plantar surface of the heel. In paediatric 
population the recommended site for capillary 
sample collection is the fingertip (1,12). Earlobe as 
a puncture site is used in mass screening or re-
search studies and for adult patients. The World 
Health Organization and CLSI guidelines on capil-
lary blood sampling state that earlobes are unsuit-
able sites for blood sampling in neonatal and pae-
diatric population (8,12). Some authors consider 
the results from earlobe sampling more reliable 
than results obtained by fingertip sampling. Nev-
ertheless, arterialized earlobe blood pO2 is not as 
reliable as arterial pO2 (11,15,16).
Venous blood is not a suitable substitute for ar-
terial blood in BGA because of the nature of the 
sample and difference in oxygenation levels 
compared with arterial  blood. It is suitable for 
the assessment of different variants of haemo-
globin, electrolytes, as well as pH, pCO2, HCO3- 
and metabolites (1).
1.4 “Mixed” venous blood
“Mixed” venous blood sample is obtained from 
the pulmonary artery by means of a pulmonary 
artery catheter and it is used to evaluate oxygen 
uptake and cardiac output (1).
2 . Responsibilities in blood gas testing
Arterial blood sampling should only be performed 
by healthcare workers within the described legal 
scope of practice for their position in their country 
and who have demonstrated proficiency after for-
mal training (8).
Based on the Training and skill catalogue for medi-
cal study, medical doctors (MD) in Croatia must be 
able to independently perform an arterial blood 
sampling after graduation. This skill is further im-
proved during postgraduate studies and speciali-
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zation (18). Bachelor of nursing is trained in sam-
pling of arterial blood ordered by the MD (19). A 
nurse has theoretical and practical knowledge in 
sampling other samples that are used in analysis 
of acid-base status – capillary and venous blood 
samples (20).
According to the document published by the 
CCMB in 2013 “Competences for issuing the license 
for masters of science in medical biochemistry and 
specialists in medical biochemistry and laboratory 
medicine”, master of science in medical biochem-
istry post completion of the five year course, one 
year internship and passing the state license ex-
amination, has the theoretical and practical knowl-
edge of capillary blood sampling, performing BGA 
and interpretation of acid-base balance results. 
Specialists in medical biochemistry and laboratory 
medicine have additional qualifications related to 
implementation of new techniques for sampling 
and analysis of blood gases, establishment of qual-
ity control programs and should have performed 
at least 1000 analysis of acid-base status (21). They 
play a key role in education of personnel responsi-
ble for sampling which is also regulated by law 
within Regulations on medical biochemistry prac-
tice by the patient’s bedside (22). 
Table 1 shows the list of healthcare workers in Cro-
atia authorized to carry out specific procedures re-
lated to BGA.
Based on previous statements, we can conclude 
that sampling and analysis of blood gas samples 
are complex interdisciplinary processes that in-
clude a broad spectrum of medical experts, as it 
was observed from the survey conducted during 
2013 by the WG BGT (5). 
3 . Procedure for blood gas sampling
3.1 Preparation for sampling 
Preparation for sampling includes patient identifi-
cation, a pathology request form for BGA, patient 
assessment, explanation of the procedure of sam-
ple collection to the patient and regulations relat-
ed to blood gas sample labelling.
3.1.1 Patient identification
3.1.1.1 Procedure for the identification of conscious 
patient
Procedure Healthcare worker
Arterial blood sampling Doctor of medicineBachelor of nursing
Capillary blood sampling
Bachelor of nursing
Master of science in medical biochemistry
Laboratory technician
Blood gas sample analysis
Master of science in medical biochemistry
Laboratory technician
Bachelor of nursing (after education is performed by laboratory personnel)
Quality control
Master of science in medical biochemistry
Laboratory technician
Bachelor of nursing (after education is performed by laboratory personnel)
Result interpretation Master of science in medical biochemistryDoctor of medicine
Implementation of blood gas equipment Specialist in medical biochemistry and laboratory medicine
Personnel education Specialist in medical biochemistry and laboratory medicine
Table 1. List of healthcare workers in Croatia authorized to carry out specific procedures related to BGT based on the available legis-
lation and practices observed in the Croatian laboratories (5,18-22).
Personnel responsible for the sampling proce-
dure should ask the patient to state his/her first 
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In addition to the abovementioned items, the fol-
lowing information are needed for correct inter-
pretation of BGA: 
•	 collection site and sampling technique (e.g. ar-
terial blood collected by arterial puncture or 
from arterial catheter), 
•	 patient ventilatory status, 
•	 mode of ventilation and information on oxygen 
supply,
•	 respiratory rate, body temperature, patient po-
sition and activity, including special remarks 
(e.g. anxiety),
•	 name of the person collecting the sample, 




Positive patient identification is required as stated 
by the procedure recommended by the Working 
Group for Pre-analytics of CSMBLM (23), needing 
at least two identifiers (e.g. full name (first and last 
name) and date of birth) for patient safety (24).
3.1.1.2 Procedure of identification in patient who is 
unable to give personal details
and last name and date of birth, and then com-
pare the details with the details written on the 
test request form. Discrepancies should be re-
solved prior the sampling procedure with the 
responsible person in the area. Use of at least 
two identifiers is needed for patient safety.
If it is not possible to obtain personal details di-
rectly from the patient, the person responsible 
for the patient (caregiver, family member, nurse) 
should be asked to identify the patient and pro-
vide the required details. Name of the verifier 
should also be documented.
3.1.2 Test request form for BGA
The following items should be stated in the test 
request form: the patient’s first and last name, 
gender, date of birth, personal identification 
number or health insurance number, date and 
time and sampling location (hospital ward) 
(23,26). The test request form should contain 
the name of the responsible person who reque-
sted BGA (27). Contact information of the res-
ponsible person is needed for critical result re-
porting and consulting in the case of suspected 
non-conformities.
For correct assessment of the patient’s condi-
tion, body temperature (6), respiratory rate and 
activity including special remarks (e.g. anxiety) 
need to be recorded (28).
Changes in body temperature have impact on 
blood gas values because of the shift in chemical 
equilibrium, while physical activity and anxiety 
can cause an increase in the respiratory rate (1,29).
3.1.3.1. Assessment of ventilatory changes
 It is recommended that patient remains in a re-
laxed state for at least five minutes before sam-
pling in order to establish stabile state (7).
Urgent blood gas sampling and analysis in criti-
cal care settings is performed immediately for 
prompt evaluation of the patient vital functions. 
In situations when ventilatory changes have 
been made to patients, it is recommended to 
wait for 20 to 30 minutes to reach the ”steady-
state“ and to obtain reliable blood gas results.
3.1.4 Explanation of the sampling procedure to the 
patient
Patient should be informed in detail about the 
procedure of specimen collection (30).
3.1.1.3. Procedure for the identification of unidentified 
emergency patient.
Master (temporary) identification patient num-
ber for the unidentified emergency patient 
should be defined according to the institutional 
policy. When a permanent identification num-
ber is assigned to the patient, the temporary 
identification number should be cross-refer-
enced to the permanent number (25).
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3.1.5 Sample labelling Information and education of clinical and nursing 
personnel encompasses the following issues:
•	 Sample device,
•	 Anticoagulant,
•	 Sampling procedure – arterial puncture and 
collection of a sample from arterial catheter (air 
bubbles expulsion; sample mixing; flushing of 
the catheter),




Figure 2. Recommended capillary blood gas sample labelling 
(source: Wennecke G, Dal Knudby M. Avoiding preanalytical er-
rors – in capillary blood testing. Radiometer Medical Aps, Brøn-
shøj, Denmark, 2009.)
A sample for BGA should be labelled with the 
patient’s full name and second identifier. Institu-
tional policy defines the second identifier, which 
could be: date of birth, health insurance number 
or identification number.
A capillary sample should be directly labelled 
with the label containing two patient identifiers 
immediately after the sampling procedure and 
before leaving the patient (31). Figure 2. shows 
recommended capillary sample barcode label-
ling. Arterial sample should be directly labelled 
with the label containing two patient identifiers 
(32).
3.2 Arterial blood sampling procedure
Laboratory personnel are responsible for appro-
priate written instructions for sample collection 
according to the ISO 15189 standard (27). Arteri-
al blood collection is performed by physicians 
(18) and nursing graduates (19) in healthcare in-
stitutions in Croatia. In order to ensure arterial 
sample quality and result reliability, laboratory 
personnel should inform ward personnel re-
sponsible for arterial blood collection of the re-
quired procedures. 
Arterial blood sampling device, as stated in CLSI 
C46-A2 document, should be a plastic, disposa-
ble, self-filling syringe. Self-filling syringes fill 
spontaneously with arterial punctures. Collector 
needs to be aware of the minimal volume need-
ed for reliable measurement of all requested pa-
rameters (32,33). Minimal blood volume in the 
syringe is recommended to ensure accurate re-
sults are obtained and to cause minimal blood 
loss for the patient.
3.2.2 Anticoagulant
Use of lyophilized, balanced lithium heparin is 
recommended for BGA and related measure-
ments in arterial and capillary blood samples. It 
is acceptable to use anticoagulant in spray and 
dried form. Sodium heparin is not recommend-
ed as it causes falsely high sodium values. Use of 
liquid (therapeutic) heparin should be avoided 
because of dilution effect on blood gas and re-
lated parameters and ability to bind electro-
lytes, namely calcium. Erroneous results can 
arise from improper anticoagulant concentra-
tion and insufficient mixing of anticoagulant 
and blood sample (33-35). Different prepara-
tions of heparin by syringe manufacturers can 
be a source of variability of BGA results (36).
3.2.3 Sampling procedure – arterial blood gas 
sample
Examination of collateral circulation is obligatory 
when arterial blood sampling is performed from 
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the radial artery. After aseptic preparation of punc-
ture site, dedicated collection device designed for 
arterial collection should be used. This procedure 
is needed to avoid accidental contamination of ar-
terial sample with venous blood. 
When the syringe has been filled with adequate 
blood, withdraw the syringe, place a dry gauze 
sponge on the puncture site and press firmly on 
the puncture site for 3-5 minutes. Arterial blood 
should be collected under anaerobic conditions to 
minimize air exposure (1). 
Air bubbles should be immediately expelled from 
the syringe by gently tapping the sides of the sy-
ringe allowing them to go to the top of the syringe 
for expulsion in order to avoid an air contamina-
tion and falsely altering the pO2 results (37).
Following air-bubbles expulsion, homogenization 
of the sample with the anticoagulant should be 
done to avoid formation of the clots. For optimal 
anticoagulation, rolling of the syringe between 
the palms, and then inverting it vertically is recom-
mended (Figure 3.).
Warning: Vigorous mixing can cause significant 
changes in blood gas and related measurement 
values due to haemolysis (38,39). 
3.2.4 Sampling from arterial catheter
During sampling from an arterial catheter, there is 
a risk of contamination of specimen with intrave-
nous solution, medication or diluting the sample 
with electrolyte solution (e.g. NaCl) that may be in 
the catheter (1). If the catheter is not flushed suffi-
ciently, sodium and chloride will be elevated 
whereas all other analytes will be falsely lower (32). 
When an arterial specimen is to be collected from 
an arterial catheter, the catheter must be flushed 
prior the sampling. Recommended flushing vol-
ume is at least 3 times the dead volume of the 
catheter. Manufacturer’s specification for the re-
quired dead volume is recommended to be used 
for the catheter. 
3.2.5 Transport
Figure 3. Mixing of the arterial blood sample (source: Wen-
necke G, Juel G. Avoiding preanalytical errors – in blood gas 
testing. Radiometer Medical Aps, Brønshøj, Denmark, 2008.)
Samples for BGA should be analyzed as soon as 
possible. Arterial samples taken into standard, 
recommended plastic syringes should be ana-
lyzed within 30 minutes. Hand transport of sam-
ples without sudden, vigorous movements is 
recommended. Risk of haemolysed and air-con-
taminated sample is higher if the sample is sub-
jected to shaking. Transport of samples on ice is 
not recommended because plastic syringes are 
more permeable to gases at lower temperatures 
and due to the high risk of haemolysis. Exact 
times of the sampling and delivery of the sam-
ple to central laboratory for analysis should be 
recorded. If the time between sampling and de-
livery to the laboratory exceeds the allowed sta-
bility interval (30 minutes), non-conformity 
should be recorded and ward personnel in-
formed on need to recollect.
3.2.6 Storage – arterial blood gas samples
Due to cellular metabolism in whole blood 
specimen, blood gas and related parameters 
can change rapidly and significantly, so immedi-
ate analysis upon collection is highly recom-
mended. Samples with high leukocyte and 
platelet count and samples intended for special 
studies (e.g. shunt analysis) need to be analyzed 
within 5 minutes.
BGA within 30 minutes gives reliable results ex-
cept in the presence of an elevated leukocyte or 
platelet count (40). In that case, glass syringe 
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should be used (if available) and immersed into 
mixture of ice and water (41) or recollection and 
immediate transport for analysis.
3.3 Capillary blood sampling procedure
3.3.2 Arterialisation of the skin puncture site for 
capillary sampling
It is highly recommended that the puncture site 
be arterialized prior to capillary sampling (42). This 
procedure will give similar results to the ideal sam-
ple, arterial blood gas sample.
To achieve arterialisation, the puncture site should 
be covered with a warm, moist towel heated at 42 
°C or less for 3-5 min prior to puncture. This is the 
recommended arterialisation method because its 
application does not produce adverse effects. 
Vasodilatory creams based on capsaicin, or nicoti-
nate and salicylate or 2% nitroglycerine cream can 
be used, but precaution measures are needed due 
to potential adverse effects listed in package in-
sert. Application of vasodilatory cream is per-
formed by spreading of cream on the puncture 
site prior sampling. Following application, cream 
should be left on puncture site until becomes red 
and warm, which can take from 5 to 20 minutes. 
After proper arterialisation is achieved, the punc-
ture site should be cleaned with the clean gauze 
and capillary blood gas sampling can be per-
formed. All the steps in capillary sampling are de-
scribed in the national recommendations by CSM-
BLM for capillary sampling (42). These steps in-
clude:
•	 Disinfection of the puncture site with 70% 
aqueous solution of isopropanol;
•	 Air drying of the puncture site;
•	 Skin puncture and wiping away of the first drop 
and
•	 Anaerobic collection of the blood from the cen-
tre of the second spontaneously formed blood 
drop.
Applying pressure (“milking”) of the puncture site 
during the sampling should be avoided. Conse-
quences of “milking” are haemolysis and sample 
contamination  with tissue fluid.
Each laboratory should follow minimal volume 
specifications defined by the blood gas analyzer 
manufacturer and use appropriate capillary tubes. 
Balanced lyophilized lithium heparin is the recom-
mended anticoagulant. Spray and dried form of 
this anticoagulant are acceptable.
Sample collection should be as described in the 
national recommendations of the CSMBLM for 
capillary blood sampling (42).
Capillary sampling intended for BGA is recom-
mended for neonatal and paediatric population 
in the first instance. Capillary blood gas sam-
pling is recommended for adult patients only in 
situations when arterial blood puncture cannot 
be performed (patients with severe burns, ten-
dencies to thrombosis, obese and geriatric pa-
tients).
General recommendations regarding the location 
of skin puncture are: (a) the puncture must be per-
formed on the palm-up surface of the distal seg-
ment (fingertip) of the middle or ring finger, (b) 
the middle finger and ring finger are recommend-
ed for capillary sampling, while the thumb and in-
dex finger are more sensitive and calloused, (c) the 
skin of the smallest finger is very thin, so this finger 
is not recommended for capillary sampling. 
It is not allowed capillary sampling from fingers in 
neonatal population, but from the side of the heel.
3.3.1 Earlobe skin puncture 
Despite the fact that current CLSI and WHO guide-
lines do not give priority to earlobe skin puncture, 
objective evidence point out the advantages of 
this puncture site in adult patients compared to 
the fingertip in cases when arterial blood sam-
pling is not feasible. Blood adequately sampled 
from an earlobe resembles more closely the com-
position of arterial blood in comparison to blood 
sampled from a fingertip (11,15,16). When the ear-
lobe puncture site is selected, capillary blood sam-
pling procedure needs to be performed according 
to the national recommendations for capillary 
blood sampling (42).
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Anaerobic filling of blood sample is needed in or-
der to prevent changes in results caused by atmos-
pheric air contamination of the sample. When cap-
illary filling is completed, immediate capping 
should be performed in order to avoid exposure of 
the sample to air. Thorough mixing with the anti-
coagulant is needed in order to prevent clotting. 
For that purpose, metal mixing bar and magnet 
are used. National recommendations on behalf of 
CSMBLM for capillary blood sampling advises the 
capillary end that is in direct contact with the 
blood to be capped first, insert a metal mixing bar, 
and then cap the other end of capillary. A magnet 
should be moved from one end of the capillary to 
the other for five times. In this way sample is ho-
mogenised with the metal mixing bar while pre-
venting clot formation (42).
3.3.3 Capillary blood sample transport and storage
4.2 Confirmation of patient’s identification
The general recommendation is to analyze the 
capillary sample immediately. Samples collect-
ed in capillary tubes should be analyzed within 
10 minutes. Samples should be kept at room 
temperature until analysis. If storage is longer, 
samples should be collected in glass capillary 
tubes and stored horizontally at 0–4 °C (im-
mersed into mixture of ice and water to avoid 
haemolysis) for a maximum of 30 minutes.
4 . Blood gas sample analysis
4.1 Personnel education and training
BGA should be performed by trained laboratory 
personnel. Complete training requirements 
should be documented in laboratory standard 
operating procedures. The competence of em-
ployees responsible for BGA should be evaluat-
ed for new employees and the competence re-
evaluated annually. Training and competency 
records for all staff should be retained as per re-
quirements of good laboratory practice.
Time of the delivery of the blood gas sample to 
the central laboratory should be recorded. Time 
between sampling and analysis should not ex-
ceed 30 minutes. If it  exceeds the recommend-
ed time interval, clinical staff should be in-
formed and recollection requested. 
Prior to analysis, the employee responsible for 
sample analysis should check the detail on the 
specimen label match those on the test request 
form to confirm the patient’s identification. If 
the specimen needs to be immersed into an ice 
slurry (mixture of ice and water) until the analy-
sis can be performed (i.e. if delay of more than 
30 minutes is anticipated), the label integrity 
must be protected even during immersion (7).
4.3 Sample preparation prior to analysis
The quality of the whole blood sample should 
be inspected before analysis. Blood gas samples 
containing air bubbles or visible clots are unac-
ceptable for analysis.
Proper mixing of whole blood samples is critical 
for obtaining accurate haemoglobin results. 
Capillary samples should be mixed using a met-
al bar and magnet. The magnet should be 
moved from end to end over the capillary until 
the blood components are uniformly distribut-
ed (homogenized) or for at least 5 seconds. One 
end of the capillary should be opened by care-
fully removing the sealant cap. The metal bar 
should be removed by pulling the magnet slow-
ly over the capillary, being careful not to spill 
blood or introduce air into the sample. Before 
introducing the sample into the analyzer, the 
opposite end of the capillary should be opened 
by removing the remaining sealant cap and the 
sample should be allowed to flow to the end to 
remove trapped air. The capillary should then 
be presented to the instrument nozzle, adapter 
or aspirator tip. Analysis should be initiated as 
described in the specific instrument instruc-
tions.
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According to CLSI (1) recommendations arterial 
samples should be gently rotated, either manu-
ally or using a mechanical device that rotates 
the sample through two axes, for a minimum of 
one minute immediately prior to analysis.
Data on patient’s body temperature and oxygen 
supply can be entered in some analyzers, enabling 
the correction of obtained BGA results to patient’s 
current body temperature and for special calcula-
tions for which data on oxygen supply are needed. 
These additional features should be implemented 
only after adequate education of personnel in-
volved in BGA.
The pH of freshly drawn blood decreases on stand-
ing at a rate of 0.02 to 0.03 pH unit/h at 22 °C and < 
0.01 pH unit/hour at 4 °C. This decrease in pH is ac-
companied with a corresponding decrease in glu-
cose and increase in lactate and pCO2 in the sam-
ple mainly due to glycolysis and cell respiration. 
Unwanted effects on pH and blood gases can be 
prevented by analyzing the sample immediately, 
within 30 minutes from collection. 
Samples with elevated white blood cell counts 
must be analyzed immediately due to the marked 
effect of increased glycolysis in pH, blood gases, 
and lactate (44,7).
When syringe samples are introduced into the an-
alyzer by aspiration, an air bubble will form in the 
remainder of the sample. Expel the air immediate-
ly in case the measurement needs to be repeated.
The sample should be reanalyzed immediately 
(preferably on another analyzer if available) if 
questionable results are obtained (i.e. inconsistent 
with the patient’s past results or current clinical 
status), before the quality of the sample deterio-
rates rapidly (1).
To ensure traceability after analysis, BGA samples 
should be stored as described by the CCMB docu-
ment “Sample storage and preparation” (45).
4.5 Instrumentation’ maintenance 
Specimen integrity checks should be performed 
before analysis: in case of air bubbles presence, 
clots, insufficient sample volume or any other non-
conformities, analysis should not proceed and re-
collection should be requested.
Blood used for the measurement of blood gases 
and related analytes should be thoroughly mixed 
immediately prior to analysis to achieve a homo-
geneous sample prior to insertion of sample into 
the instrument. The process of mixing should not 
alter the integrity of the sample, causing haemoly-
sis, and thus affect the quality of results (1,34).
Shorter mixing intervals are acceptable if only one 
or two minutes (or less) have elapsed since the ar-
terial sample collection. Stored syringe samples 
should be mixed by inverting the syringe 10 times 
and then rolling it horizontally between the palms 
for 10 seconds. Upon storage, samples tend to set-
tle and may require a longer mixing time to insure 
homogeneity (43).
Incomplete dissolution of anticoagulant in the sy-
ringe due to inadequate mixing immediately after 
collection can result in the formation of blood 
clots. The presence of clots in the sample renders 
it non-homogeneous and can affect the accuracy 
of analysis. Furthermore, clots can block the path-
way of the blood gas analyzer and give either con-
founding results or render the analyzer inopera-
ble. Potassium concentrations measured by blood 
gas analyzer can be spuriously increased due to 
haemolysis during clot formation. 
4.4 Sample analysis 
To ensure patient safety, patient data should be 
entered in the analyzer or laboratory informa-
tion system (manually or using the bar-code 
reader, if available) and checked according to 
the manufacturers’ instructions. Time of the 
sample’s analysis should be recorded.
The wide availability of instruments and calibra-
tion materials has made reliable and accurate 
measurement of the available analytes mainly 
dependent on regular maintenance, adherence 
to manufacturer’s recommended procedures, 
control of the equipment and proper collection 
and handling of samples. Each laboratory should 
follow the manufacturer’s recommendations for 
maintenance for optimal analyzer performance.
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4.6 Results reporting
In addition to blood gas (and/or other analytes) va-
lues and patient’s identification data, a complete 




•	 results release time,
•	 sample type (i.e. arterial, capillary) and sam-
pling mode,
•	 any ventilator settings, mode of ventilation and 
information on oxygen supply,
•	 the type and location of any fluid infusions,
•	 the collection site,
•	 respiratory rate, 
•	 body temperature and
•	 the patient’s posture and activity with special 
remarks on patient status (e.g. anxiety).
Comments regarding quality of the sample, trans-
portation delays and improper storage should also 
be documented.
4.7 Analytical interferences
ly elevated chloride concentrations. If chloride 
electrode is repeatedly exposed to the anticoagu-
lant heparin (e.g. when attempting to wash out 
clots from the analyzer), due to its negative charge 
it could be extracted to the chloride membrane 
resulting in the reduction of membrane sensitivity 
for chloride ions. 
Sensors for glucose and lactate are susceptible to 
interference from endogenous and exogenous ox-
idizable substances present in blood (uric acid, 
ascorbic acid, acetaminophen, and dopamine). 
Fluoride and oxalate, typically used as additives in 
blood collection tubes, could produce a negative 
interference on glucose and lactate biosensors by 
inhibiting the activities of oxidase enzymes used 
in the measurement reaction.
Variation in electrolyte and protein concentrations 
may interfere with haematocrit conductivity meas-
urements. 
The presence of fetal and rarely sulfhaemoglobin 
(i.e. aberrant haemoglobins) produces interferenc-
es with co-oximetry measurements. The therapeu-
tic administration of hydroxycobalamin and meth-
ylene blue (which are coloured and interfere with 
spectrophotometric measurements used in co-ox-
imetry) may affect haemoglobin fraction measure-
ment (1). 
Haemolysis has a significant effect on potassium 
concentrations because of the concentration gra-
dient present between cells (erythrocytes, leuco-
cytes and platelets) and plasma. Haemolysis may 
cause erroneously low sodium and ionized calci-
um concentrations due to dilution effect. Other 
analytes may be affected as well, depending on 
the level of haemolysis (1,38). Although the pres-
ence of haemolysis in whole blood samples is im-
possible to detect visually, it has been shown to 
cause unreliable pO2 and pCO2 results (i.e. signifi-
cantly lower pO2 and higher pCO2, respectively). 
Furthermore, haemolysis may cause a clinically im-
portant decrease in sO2 and carboxyhaemoglobin 
(COHb). If a result is obtained that does not reflect 
the patient’s condition, the presence of haemoly-
sis should be suspected and investigated by trans-
ferring the whole blood sample into an additive 
free tube and expose it to rapid centrifugation 
Laboratories need to be familiar with the ana-
lyzer limitations, especially those regarding po-
tential interferences.
Polymeric pH sensors, typically used in cartridge-
based analyzers, as well as blood gas and related 
analytes sensors, are subject to interferences from 
lipophilic compounds like perfluorocarbon found 
in emulsion based quality control (QC) materials. 
Cationic surfactants, especially benzalkonium 
compounds, may interfere with sodium, potassi-
um and ionized calcium measurements (46). Ion-
ized magnesium sensors are subject to ionized cal-
cium and sodium interference. Thiocyanate con-
centrations commonly present in smokers may 
cause a decrease in ionized magnesium concen-
trations (1). Chloride sensors are based on ion ex-
change membranes and thus are susceptible to in-
terferences caused by more lipophilic anions (oth-
er than chloride) present in the sample. Salicylates, 
thiocyanates, bromides and iodides produce false-
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(28,38). Sample lipemia interferes with the meas-
urement of total haemoglobin and haemoglobin 
fractions (1,34). 
Methods for the measurement of haematocrit on 
blood gas analyzers include calculation from the 
measured total haemoglobin concentration or its 
measurement by conductivity. The conductivity 
measurement is dependent on electrolyte con-
centrations and thus susceptible to its variations. 
Additionally, abnormal protein concentrations (i.e. 
low protein concentrations resulting from blood 
dilution with electrolyte solutions) result in spuri-
ously low haematocrit values measured by con-
ductivity. The calculation of haematocrit from 
measured total haemoglobin concentration as-
sumes a normal MCHC value (about 340 g/L). Dis-
orders resulting in abnormal MCHC values (micro-
cytic and/or macrocytic anaemias, hereditary 
spherocytosis, and sickle cell disease) influence 
the calculation’s accuracy. MCHC values can be af-
fected by erythrocytes aggregation due to pres-
ence of agglutinins.
The absorption spectra of fetal and adult haemo-
globin differ slightly and the presence of elevated 
concentrations of fetal haemoglobin may cause 
falsely elevated carboxy- and/or methaemoglobin 
concentrations. Some analyzers can correct for the 
presence of fetal haemoglobin (1,28).
The choice of anticoagulant can affect blood gas 
and related measurements. It has been already 
stated that the anticoagulant of choice in blood 
gas and related measurements is lyophilized, bal-
anced heparin. Spray and dried form of anticoagu-
lant is acceptable, too. If liquid heparin is used in-
stead, it may cause erroneous results by dilution 
effect on all analytes and/or interfere with ionized 
calcium measurements by binding it. Sodium hep-
arin may falsely increase sodium concentrations. 
The use of therapeutic heparin for BGA is not rec-
ommended since it may alter ionized calcium, 
magnesium and pH measurements. EDTA and oxa-
late anticoagulants are not used for blood gas 
analysis because they may interfere with electro-
lyte or enzymatic measurements by chelating cati-
ons (1,28). 
Lubricants and additives could be present in sy-
ringes that may interfere with co-oximetry meas-
urements. Syringe and instrument manufacturers 
should be contacted for further specific informa-
tion (1).
Contamination of the sample with “line draw” fluid 
from an indwelling catheter may lead to clinically 
significant dilution errors (28).
4.8 Calibration
Operators should adhere to analyzer specific 
calibration procedures recommended by the 
manufacturer. Calibration materials should be 
traceable to certified reference materials. To 
meet acceptable analytical performance for 
clinical application, traceable QC materials and a 
proper proficiency testing program should be 
instituted (1).
Each analyzer has recommended calibration pro-
tocols that include specific calibration materials 
and frequency (depending on the stability of the 
technology used for measurement). Many analyti-
cal systems have a built-in calibration check which 
is performed after every system calibration. This 
process allows timely error detection before run-
ning QC and patient samples. Unfortunately, due 
to matrix effects, the recovery of expected calibra-
tor values may not accurately reflect the perfor-
mance with patient samples (1).
The traceability of calibrators used should be doc-
umented by a manufacturer’s statement regard-
ing traceability and associated uncertainties. Pri-
mary pH standards should be traceable to the ref-
erence method for pH, calibrated with Standard 
Reference Material (SRM) 186 I and 186 II. Manufac-
turers should use blood tonometry with gas mix-
tures of certified composition (SRM available from 
National Institute of Standards and Technology, 
NIST) as a reference method for establishing accu-
racy for pO2 and pCO2 measuring devices. Haemo-
globin fractions are based on absorbance ratios 
and do not require separate calibrations if the 
measuring wavelengths remain unchanged. Pri-
mary standards for potassium, sodium and chlo-
ride determination are gravimetric solutions pro-
duced from KCl and NaCl salts of high purity trace-
able to SRM 918, SRM 919 and SRM 999, respec-
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tively. The primary ionized calcium standard is 
produced from CaCO3 buffered to pH = 7.4 and 
traceable to NIST SRM 915. The primary glucose 
standards are traceable to SRM 917a (D-glucose). 
Their glucose concentration is assigned using the 
glucose reference method. Since no certified SRM 
for lactate is available, primary standards are pre-
pared from a pure commercially available lithium 
lactic salt.
If traceable standards do not exist for a particular 
analyte, traceability requirements may be met by 
using certified materials of known purity with reli-
able physical and chemical characterization, use of 
specified methods and/or consensus standards or 
participation in a suitable program of inter-labora-
tory comparisons (1).
4.9 Quality control for blood gas analysis and 
related measurements
Quality control (QC) for blood gas and related 
measurements is particularly important because 
these tests are requested predominantly in criti-
cally ill patients and treatment is instituted imme-
diately upon test results receipt. Internal QC veri-
fies the attainment of analyzer’s analytical perfor-
mance to the appropriate criteria for intended use 
(27,47).
patient’s samples should be implemented as a 
useful adjunct to daily QC testing. At least one 
daily comparison of each analyte measured is 
recommended.
Each laboratory should design the internal QC 
analysis strategy in accordance with require-
ments of good laboratory practice.
It is recommended to perform the simultaneous 
analysis of at least two levels of commercial QC 
materials daily to evaluate the analytical quality 
of the measurement system. QC materials 
should cover the measuring range and possibly 
the critical clinical points. QC materials inde-
pendent of those produced by the analyzer’ 
manufacturer is suggested but this may not be 
attainable with cartridge based analysers.
Procedures to be followed in case of unaccepta-
ble QC results should be documented and insti-
tuted as required.
If multiple blood gas analyzers are used for BGA 
and related measurements, comparisons using 
The recommendations stated above represent the 
minimal QC requirements for blood gas and relat-
ed measurements. Laboratories are strongly en-
couraged to define their own quality goals for BGA 
and related measurements and then tailor specific 
QC protocols to ensure that every patient’s test re-
sult meets the stated quality goal (27,47). QC re-
sults must be reviewed and acted upon in a timely 
manner, as per laboratory procedures, to assure 
confidence of reported results. The critical ques-
tion in blood gas QC protocols is the strategy of 
QC testing (i.e. number, type and frequency). QC 
frequency is highly dependent on frequency of 
BGT (i.e. workload), acceptability of quality control 
results, manufacturer’s recommendations and reg-
ulatory requirements. For example, the CLIA re-
quirements for BGA are stringent: at least one QC 
sample every 8 hours of testing and 3 levels (low, 
normal and high) each 24 hours of testing. The 
practical answer would be to run on every analyz-
er in use, at least once per 8 hours, 3 levels of con-
trol for pH, pO2 and pCO2, and additionally, always 
on completion of maintenance and troubleshoot-
ing procedures (27,44,47,48). 
If multiple blood gas analyzers are closely located in 
the laboratory or hospital site, a single sample 
should be analyzed on a number of analyzers, with-
in a short period of time, considering sample labili-
ty. If analysers, which measure sO2 by co-oxymetry, 
and those which calculate sO2 are used interchange-
ably in the same laboratory, the comparability of 
measured and calculated sO2 results should be veri-
fied. If multiple blood gas analyzers are dislocated 
in a laboratory or hospital site, patient samples 
should not be used. Instead, the acceptable analyti-
cal performance of the analyzer should be verified 
using established internal QC protocols. 
If blood gas analyzers are located closely to the 
main chemistry analyzer, and measurements of 
electrolytes and/or metabolites from serum/plas-
ma and whole blood samples are performed in 
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the laboratory, an ongoing comparison of the two 
platforms should be instituted. It should be per-
formed by analyzing serum/plasma samples on 
multiple measurement systems. The differences in 
measuring techniques and sample types should 
be taken into consideration when interpreting the 
obtained bias (44).
Commercially available QC materials for BGA and 
related measurements include blood-based solu-
tions containing free haemoglobin, emulsion-
based and buffered aqueous fluid control materi-
als. They may be introduced by the operator or in-
tegrated in the analytical system and analyzed au-
tomatically (1).
Buffered aqueous QC solutions typically simulate 
blood with respect to pH and pCO2, but have low 
oxygen buffering capacity and therefore poorly 
resist pO2 changes, which makes them susceptible 
to storage and handling temperature variability. 
Although most commonly used, the disadvantage 
of aqueous QC materials originates from their dis-
similarity with blood (non-commutability) in terms 
of viscosity, surface tension and electrical conduc-
tivity (1,44). Haemoglobin-containing QC materials 
consist of red blood cells or haemolysate, which 
enhances the pO2 buffering. Emulsion controls 
contain oils (typically perfluorocarbon) in buffered 
aqueous salt solutions. While they are better in re-
sisting oxygen change than aqueous solutions, 
their surface tension and density are not identical 
to that of blood. QC materials sealed in ampoules 
contain a gas mixture phase in the headspace and 
must be equilibrated to the appropriate tempera-
ture before opening (if room temperature is signif-
icantly different from 25 ˚C). QC solutions for oxi-
metry consist of a mixture of dyes simulating the 
absorbance readings of deoxy-, oxy-, carboxy- and 
methaemoglobin mixture over a wide range of 
clinically important concentrations (1). Commer-
cially available QC materials should be handled 
and prepared for analysis according to manufac-
turer’s recommendations. Newer blood gas ana-
lyzers have an on board QC cartridges automated 
QC capability and/or use “electronic QCs”. Auto 
QCs consist of on board QC materials that are au-
tomatically analyzed by the instrument at desig-
nated time intervals (regulatory or manufactur-
er’s). Such QCs may check the test system’s analyti-
cal components completely or partially, and may 
be used in combination with traditional external 
QCs. They monitor temperature, incubation time, 
correct sample or reagent volume transfer, integri-
ty of the sample (blood clots), and report to the 
operator failures of acceptable operational limits. 
In these cases, some analysers may even automati-
cally initiate and document corrective actions. 
These integrated QCs are consistent and require 
little or no operational intervention. It is highly 
recommended to use commercial QC materials for 
proper monitoring of system performance (1).
Electronic QCs consist of cartridges that verify the 
electronic components of BGA analyzers. Since 
electronic QCs cannot verify the analytical perfor-
mance of the analyzer, additional commercial QC 
materials should be analyzed concomitantly (1).
4.10 Proficiency testing for BGA and related 
measurements
Laboratories should participate in proficiency 
testing (PT) programs for BGA and related meas-
urements organized by the Croatian centre for 
quality assessment in laboratory medicine 
(CROQALM) of the CSMBLM.
Alternatively, if analytes of interest are not provid-
ed by the CROQALM, external independent PT 
providers are suitable. 
A minimum of 3 PT cycles per year is recommend-
ed, which is the common frequency of BGA for 
CROQALM.
The obtained PT results should be reviewed by ap-
propriate personnel and the actions taken in case 
of unsatisfactory performance. These procedures 
should be documented (48).
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Appendix
List of comments received by public discussion of the national recommendations for BGA and answers of 
Working group for blood gas testing
Comment Authors’ response
COMMENTATOR 1
Considering that the use of warm, moist towel at a temperature 
not higher than 42 °C is not convenient for routine use, I suggest 
that you explain in detail arterialisation of capillary sample using 
vasodilatory cream.
We thank the commentator for this comment. Section 3.3.2 
Arterialisation of the skin puncture site for capillary sampling 
describes the procedure of using vasodilatory cream for 
arterialisation of the puncture site.
I suggest revising the recommendation regarding the 
frequency of quality control procedures in 24 hours, taking into 
consideration the price of 3 commercial QC samples daily. 
The section 4.9 of the recommendations states: „Each 
laboratory should design the internal QC analysis strategy in 
accordance with good laboratory practice.“ The frequency 
of QC analysis depends on the workload, acceptability of 
quality control results, manufacturer’s recommendations 
and regulatory requirements, which is also clearly stated 
in recommendations. The analysis of 3 QC samples daily, 
mentioned by the commentator, is merely an example cited by 
the CLIA requirements, and should not be considered a national 
recommendation. 
COMMENTATOR 2
Introduction – some analyzers have also co-oxymeters (built 
in or connected to the analyzer, like the IL Premier 3000, for 
example). In case of the IL Premier 3000, the co-oximeter is 
switched on depending on the analyses requested. When the 
co-oximeter is turned on, the analyzer measures the sO2, while 
when it is turned off (in cases when only BGA is requested), the 
analyzer calculates the sO2 value. The sO2 results are reported 
interchangeably. 
If this is the case, is it necessary to perform a comparability 
study? Or, considering that requests for measured sO2 are rare, is 
advisable to always report the calculated sO2 result?
The answer to this comment is included in section 4.9 Quality 
control for blood gas analysis and related measurements, in the 
paragraph referring to comparability of BGA results. 
Table 1 – it has not been specified which document states 
competences of laboratory staff; also, there are no bachelors of 
laboratory diagnostics on the list.
We thank for this comment. Table 1 represents a summary 
of data from the text, i.e. of the literature that describes 
competences of individual professions in health care in Croatia 
regarding blood gas analysis and common practice in Croatian 
laboratories. We have therefore added in the table title a list of 
references that refer to stated data.
In order to simplify quotation for different levels of education 
(high school, undergraduate, graduate and postgraduate level), 
the working group decided to use only a general term for a 
particular profession that deals with a specific area (e.g., doctor, 
nurse).
For this reason, the table does not use the term „bachelor of 
medical laboratory diagnostics“ but only the broader term 
„laboratory technician“.
The goal of this section was to show interdisciplinary areas and 
professions involved in blood gas analysis. 
Sample analysis – the option of including data on patient’s body 
temperature and oxygen supply for the calculation of corrected 
values of BGA is not described. This is especially important for 
patients in intensive care units.
The section 4.4 Sample analysis of the national 
recommendations was rephrased in order to answer this 
comment.
Is a sample containing a blood clot never acceptable for BGA, 
or are there special circumstances that allow the reliable 
measurement of any BGA parameter?
The section 4.3 of the national recommendations states: 
„Blood gas samples containing air bubbles or visible clots are 
unacceptable for analysis.“ Therefore, a sample containing a 
visible clot is not acceptable for BGA, under any circumstances. 
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Quality control – comparability using patient’s samples – is a 
patient single arterial blood sample suitable for comparability 
studies, especially with respect to pO2? Could a serum sample 
or a lithium heparin plasma sample, aliquoted in multiple 
stoppered containers (depending on the number of the 
analysers compared) be used for this purpose instead?
The section 4.9 of the recommendations states that an ongoing 
comparison should be instituted using the same patient 
sample, in a short time period, on blood gas analysers located 
closely. Sample (in)stability should be always considered 
(especially regarding pO2). When selecting a sample for 
comparability control, the manufacturer instructions on sample 
type recommended for analysis have to be followed. 
Sample storage after analysis – it is not specified if BGA samples 
should be stored after analysis and how long, for traceability 
purposes only. The CCMB recommendations are available online.
We thank for this comment. The recommendations were 
modified according to this comment in the section 4.4 Sample 
analysis.
COMMENTATOR 3
„A capillary blood sample can replace an arterial sample only 
when an arterialisation technique is used, although entirely 
reliable pO2 measurement can be achieved only when an 
arterial blood sample is used.“ 
Results of the survey on procedures in acid-base testing in 
Croatian laboratories show that 46% of laboratories use capillary 
sample for blood gas analysis in adults. Further, according to 
national recommendations of the Croatian Society of Medical 
Biochemistry and Laboratory Medicine for capillary blood 
sampling, results of the survey showed that as much as 88% of 
laboratories never use arterialisation before capillary sampling. 
Therefore, I think that considerable attention should be given 
to arterialisation of capillary sample. As your document has 
a section entitled Procedure for blood gas sampling, I think 
that procedure of arterialisation should be explained in more 
detail, because of situations when there’s no possibility to 
collect arterial blood (geriatric patients, burn etc.). Maybe 
arterialisation procedure could be more accepted and more 
present in laboratory practice if a more detailed protocol was 
described. You quote: “detailed procedure of arterialisation 
and all steps for capillary sampling are described in the 
national recommendations of the Croatian Society of Medical 
Biochemistry and Laboratory Medicine for capillary blood 
sampling”, but unfortunately there are no  more details than 
in your text. It should be clarified what is meant by a towel 
(whether it would be proper to use a sterile disposable gauze), 
how to ensure temperature not higher than 42 °C, whether 
dry warm air should be used, or maybe you can suggest 
which cream to apply (a cream that contains hyperaemic or 
vasodilatory agent – which are those substances?). In addition, if 
a cream is used, how and when disinfection of the puncture site 
is performed?
We thank for this comment. Section 3.3.2 Arterialisation of the 
skin puncture site for capillary sampling describes the procedure 
of using vasodilatory cream for arterialisation of the puncture 
site.
The document „Competences for issuing the license for masters 
of science in medical biochemistry and specialists in medical 
biochemistry and laboratory medicine“ states: „COMPETENCES 
– in addition to all competences of the master of science in 
medical biochemistry, a specialist in medical biochemistry and 
laboratory medicine also gained competences....“
So if I understand correctly, this means that Table 1 declares 
that wherever there is a competent master of science in medical 
biochemistry, there should also be a competent specialist in 
medical biochemistry and laboratory medicine present.
We thank for this comment. As you said all competences 
relating to master of science in medical biochemistry are also 
related to specialist in medical biochemistry and laboratory 
medicine. Specialist in medical biochemistry and laboratory 
medicine has additional competences which are specific 
for that level of education and they are gained during 
specialization.
However, to avoid putting too much information in the table, 
we mention only „Master of science in medical biochemistry“ 
but it is obvious that a specialist in medical biochemistry and 
laboratory medicine also has competences of master of science 
in medical biochemistry.
More is explained in the text, and the working group believes 
that the table should remain unchanged in this segment.
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Section 3.2.2. Anticoagulant the use of liquid heparin is 
mentioned twice in the same context („Use of liquid heparin 
should be avoided because of dilution effect on blood gas and 
related parameters and ability to bind electrolytes, namely 
calcium.“ and then again „Liquid heparin anticoagulation has 
unfavourable dilution and chemical effect on BGA.“)
We thank for this comment. The text of the recommendation 
has been modified according to this comment in section 3.2.2.
“QC materials sealed in ampoules contain a gas mixture 
phase in the headspace and must be equilibrated to the 
appropriate temperature before opening (if room temperature 
is significantly different from 25˚C).” – Besides equilibrating to 
room temperature, should QC materials, sealed in ampoules, 
be vigorously mixed before analysis to equilibrate gases in 
the aqueous phase or should it be emphasized to handle 
and prepare such samples according to manufacturer’s 
recommendations?
We thank for this comment. The recommendations were 
modified according to this comment in the section 4.9.
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